SureTrader SureTrader
Home > Boards > US OTC > Medical - Healthcare >

BioLight Life Sciences Ltd. ADR (BLGTY)

BLGTY RSS Feed
Add BLGTY Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 7/26/2016 9:47:26 AM - Followers: 2 - Board type: Free - Posts Today: 0
BioLight Life Sciences Investments invests in, manages and commercializes biomedical innovations grouped into "clusters" around defined medical conditions. Its two current clusters are in ophthalmology via 100% ownership of XLVision Sciences and in cancer diagnostics via a 31.24% controlling ownership of Micromedic (MCTC.TA). XLVision technologies include IOPtiMate(TM), a laser-based noninvasive surgical treatment for glaucoma; TeaRx, a point-of-care dry-eye syndrome diagnostic test; and Eye-D(TM), a long-term controlled release drug-delivery implant platform. Micromedic diagnostic tests are designed to detect colorectal, cervical, breast, bladder, lung and other cancers. Leading key investors, holding about 45% of BioLight`s shares, are Mr. Israel Makov, Chairman of Sun Pharmaceuticals, former CEO and President of Teva Pharmaceuticals and former Chairman of Given Imaging, Mr. Dilip Shanghvi, founder of Sun Pharmaceuticals, India`s largest pharmaceutical company, and Mr. Dan Oren, founder and CEO of Dexcel Pharma, the second-largest pharmaceutical manufacturer in Israel. An additional 20% of the company`s shares are held by 3 reputable institutional investors.

For more information please visit the Company`s website at

www.bio-light.co.il
 

Portfolio Companies

http://www.bio-light.co.il.

Contacts:
BioLight
Itai Bar-Natan, CFO
itai@bio-light.co.il
Tel: +972-73-2753400

Existing Clusters

At present BioLight has two clusters that focuse on Cancer Diagnostics and ophthalmic diseases. Additional clusters are in development at various planning stages.

MicroMedicLOGO

Micromedic is a publicly traded company listed on the Tel Aviv Stock Exchange. The Company focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities (personalized medicine).

Read more >>
www.m-medic.com

xlvision-02

XLVision is BioLight’s wholly owned ophthalmic cluster.
XLVision currently has three technologies: a commercial laser-based device used to reduce intraocular pressure through glaucoma surgery without penetrating the eyeball; a multi-parameter, easy-to-read test to detect, select treatment and monitor dry eye syndrome and a long-term controlled-release drug-delivery implant platform with a first indication containing latanaprost, the most prescribed glaucoma drug.

www.xlvsciences.com

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BLGTY
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#42   BioLight Reports Successful Feasibility Clinical Study Results for midastouch017 07/26/16 09:47:26 AM
#41   BioLight Expands Its Product Portfolio With Eye Drops midastouch017 05/19/16 09:10:46 AM
#40   BioLight Reports 2015 Financial Results midastouch017 04/04/16 12:04:29 PM
#39   Bio Light's IOPtiMate System Receives Regulatory Approval in Canada midastouch017 12/21/15 10:08:35 AM
#38   BioLight Announces First IOPtiMate™ System Sale in Portugal midastouch017 12/08/15 09:29:05 AM
#37   BioLight Chugging Along Slowly But Steadily midastouch017 12/05/15 06:58:18 AM
#36   BioLight Announces Partnership With Axella Research For CellDetect® midastouch017 11/30/15 08:23:51 AM
#35   BioLight Announces Joint Investment in IOPtima Subsidiary midastouch017 11/25/15 12:47:06 PM
#34   BioLight’s Eye-D Technology to be Featured at the midastouch017 09/24/15 08:31:05 AM
#33   Valuation midastouch017 09/03/15 12:51:17 PM
#32   BLGTY: Update On Second Quarter 2015 Financial Results, midastouch017 09/03/15 12:50:49 PM
#31   Presentations to Highlight BioLight's IOPtiMate System at Upcoming midastouch017 09/02/15 08:34:47 AM
#30   BioLight Life Sciences Investments reports operational and financial midastouch017 09/01/15 11:14:56 PM
#29   BioLight Reports Positive Clinical Study Results for Identifying midastouch017 08/31/15 10:40:26 AM
#28   BioLight Announces First IOPtiMate™ System Sale in Peru midastouch017 08/13/15 11:52:38 AM
#27   BioLight Announces Upcoming Change of ADS Conversion Ratio midastouch017 07/23/15 09:09:09 AM
#26   BioLight's CellDetect test gets CE Mark clearance in Europe midastouch017 06/30/15 02:07:57 PM
#25   BioLight Obtains EU CE Mark for CellDetect® Non-Invasive midastouch017 06/30/15 10:39:07 AM
#24   BioLight Announces Collaboration With Ora, Inc. for TeaRx™ midastouch017 06/15/15 09:21:18 AM
#23   BioLight Reports First Quarter 2015 Financial Results midastouch017 06/01/15 09:43:12 PM
#22   I have very high hopes for this midastouch017 05/23/15 02:05:10 PM
#21   BioLight Announces Closing of Upsized US$6.6 Million Private Placement midastouch017 05/13/15 08:25:18 AM
#20   BioLight Announces First IOPtiMate™ System Sale in Hungary midastouch017 04/13/15 10:56:34 AM
#19   Rock-One International of Hong Kong partnered with BioLight midastouch017 04/12/15 09:14:01 AM
#18   BioLight: Developments Are Chugging Along Smoothly midastouch017 04/08/15 12:20:33 PM
#17   BioLight Announces Strategic Partnership to Significantly Expand Presence midastouch017 04/02/15 09:04:08 AM
#16   BioLight Reports Successful Clinical Study Results for Monitoring midastouch017 02/02/15 09:52:57 PM
#15   BioLight Reports Positive Clinical Study Findings for its midastouch017 02/02/15 08:46:11 AM
#14   Why BioLight Life Sciences' India entry is good midastouch017 01/19/15 01:33:18 PM
#13   BioLight Announces New Investment in Development of Ophthalmic Drugs midastouch017 01/12/15 02:13:10 PM
#12   Tie-up on cards for Biolight & Sun Pharma? midastouch017 01/07/15 09:56:42 AM
#11   Israel-based Biolight Lifesciences to introduce cancer-diagnostics products i midastouch017 12/12/14 02:32:28 PM
#10   Do you follow this company closely? What are NathanH 12/08/14 03:16:31 PM
#9   BioLight Announces IOPtiMate™ Distribution Agreement in Hong Kong midastouch017 12/08/14 09:29:12 AM
#8   "We are pleased that this medical center selected midastouch017 12/01/14 09:15:31 AM
#7   BioLight Announces First IOPtiMate™ System Sale in Poland midastouch017 12/01/14 09:14:27 AM
#6   Merriman Capital Initiates on BioLight Life Sciences Investments midastouch017 10/30/14 09:41:56 AM
#5   BioLight to Present at the Canaccord Genuity 2014 midastouch017 10/23/14 09:01:28 AM
#4   Hello.... NathanH 10/14/14 10:33:12 PM
#3   BioLight to Present its IOPtiMate™ System at the midastouch017 10/13/14 09:18:39 AM
#2   Zacks Reiterates “Outperform” Rating for BIO-LIGHT ISRAELI (BLGTY) midastouch017 10/05/14 09:55:08 AM
#1   Merriman Capital Announces Sponsorship of BioLight Life Sciences midastouch017 10/05/14 09:34:17 AM
PostSubject